Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.
Saved in:
| Title: | Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer. |
|---|---|
| Authors: | Addeo A; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland. Electronic address: alfredo.addeo@hcuge.ch., Shah PK; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Bordry N; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Hudson RD; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Albracht B; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Di Marco M; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Kaklamani V; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Dietrich PY; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Taylor BS; Division of Infectious Diseases, Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA., Simand PF; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Patel D; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Wang J; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Labidi-Galy I; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland; Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland., Fertani S; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Leach RJ; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Sandoval J; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Mesa R; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Lathrop K; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Mach N; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA. Electronic address: shahdp@uthscsa.edu. |
| Source: | Cancer cell [Cancer Cell] 2021 Aug 09; Vol. 39 (8), pp. 1091-1098.e2. Date of Electronic Publication: 2021 Jun 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34214473 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Addeo+A%22">Addeo A</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland. Electronic address: alfredo.addeo@hcuge.ch.<br /><searchLink fieldCode="AU" term="%22Shah+PK%22">Shah PK</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bordry+N%22">Bordry N</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hudson+RD%22">Hudson RD</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Albracht+B%22">Albracht B</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Di+Marco+M%22">Di Marco M</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kaklamani+V%22">Kaklamani V</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Dietrich+PY%22">Dietrich PY</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland.<br /><searchLink fieldCode="AU" term="%22Taylor+BS%22">Taylor BS</searchLink>; Division of Infectious Diseases, Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Simand+PF%22">Simand PF</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland.<br /><searchLink fieldCode="AU" term="%22Patel+D%22">Patel D</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Labidi-Galy+I%22">Labidi-Galy I</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland; Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fertani+S%22">Fertani S</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland.<br /><searchLink fieldCode="AU" term="%22Leach+RJ%22">Leach RJ</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sandoval+J%22">Sandoval J</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mesa+R%22">Mesa R</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lathrop+K%22">Lathrop K</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Mach+N%22">Mach N</searchLink>; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shah+DP%22">Shah DP</searchLink>; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA. Electronic address: shahdp@uthscsa.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130617%22">Cancer cell</searchLink> [Cancer Cell] 2021 Aug 09; Vol. 39 (8), pp. 1091-1098.e2. <i>Date of Electronic Publication: </i>2021 Jun 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130617 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-3686 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215356108%22">15356108 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Cell <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34214473 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ccell.2021.06.009 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1091 Titles: – TitleFull: Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Addeo A – PersonEntity: Name: NameFull: Shah PK – PersonEntity: Name: NameFull: Bordry N – PersonEntity: Name: NameFull: Hudson RD – PersonEntity: Name: NameFull: Albracht B – PersonEntity: Name: NameFull: Di Marco M – PersonEntity: Name: NameFull: Kaklamani V – PersonEntity: Name: NameFull: Dietrich PY – PersonEntity: Name: NameFull: Taylor BS – PersonEntity: Name: NameFull: Simand PF – PersonEntity: Name: NameFull: Patel D – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Labidi-Galy I – PersonEntity: Name: NameFull: Fertani S – PersonEntity: Name: NameFull: Leach RJ – PersonEntity: Name: NameFull: Sandoval J – PersonEntity: Name: NameFull: Mesa R – PersonEntity: Name: NameFull: Lathrop K – PersonEntity: Name: NameFull: Mach N – PersonEntity: Name: NameFull: Shah DP IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 08 Text: 2021 Aug 09 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1878-3686 Numbering: – Type: volume Value: 39 – Type: issue Value: 8 Titles: – TitleFull: Cancer cell Type: main |
| ResultId | 1 |